デフォルト表紙
市場調査レポート
商品コード
1052252

世界の患者腫瘍組織移植モデル市場:考察と予測 (2028年まで)

Global Patient Derived Xenograft Models Market Insights and Forecast to 2028

出版日: | 発行: QYResearch | ページ情報: 英文 108 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.18円
世界の患者腫瘍組織移植モデル市場:考察と予測 (2028年まで)
出版日: 2022年01月18日
発行: QYResearch
ページ情報: 英文 108 Pages
納期: 2~3営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、患者腫瘍組織移植モデル (Patient Derived Xenograft Models) 市場について調査しており、市場規模や予測、動向、成長要因および課題、タイプ・用途・企業・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • 患者腫瘍組織移植モデルの製品概要
  • 市場:タイプ別
    • 世界の患者腫瘍組織移植モデルの市場規模成長率:タイプ別, 2017 VS 2021 VS 2028
    • Mice Models
    • Rat Models
  • 市場:アプリケーション別
    • 世界の患者腫瘍組織移植モデルの市場規模成長率:アプリケーション別, 2017 VS 2021 VS 2028
    • Pharmaceutical & Biotechnology Companies
    • Contract Research Organizations
    • Academic & Research Institutions
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界の患者腫瘍組織移植モデルの販売 推定および予測 2017-2028
  • 世界の患者腫瘍組織移植モデルの収益 推定および予測 2017-2028
  • 世界の患者腫瘍組織移植モデルの収益:地域別: 2017 VS 2021 VS 2028
  • 世界の患者腫瘍組織移植モデルの販売:地域別
    • 世界の患者腫瘍組織移植モデルの販売:地域別 (2017-2022)
    • 世界の販売 患者腫瘍組織移植モデル :地域別 (2023-2028)
  • 世界の患者腫瘍組織移植モデルの収益:地域別
    • 世界の患者腫瘍組織移植モデルの収益:地域別 (2017-2022)
    • 世界の患者腫瘍組織移植モデルの収益:地域別 (2023-2028)
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第3章 競合:メーカー別

  • 世界の患者腫瘍組織移植モデルの販売:メーカー別
    • 世界の患者腫瘍組織移植モデルの上位メーカー:販売別 (2017-2022)
    • 世界の患者腫瘍組織移植モデルの販売市場シェア:メーカー別 (2017-2022)
    • 世界の上位10・上位5メーカー: 患者腫瘍組織移植モデル 2021
  • 世界の患者腫瘍組織移植モデルの収益:メーカー別
    • 世界の患者腫瘍組織移植モデルの収益:メーカー別 (2017-2022)
    • 世界の患者腫瘍組織移植モデルの収益市場シェア:メーカー別 (2017-2022)
    • 世界の上位10・上位5企業: 患者腫瘍組織移植モデルの収益 2021
  • 世界の患者腫瘍組織移植モデルの販売価格:メーカー別 (2017-2022)
  • 競合情勢の分析
    • メーカーの市場集中度 (CR5 and HHI)
    • 世界の患者腫瘍組織移植モデルの市場シェア:企業タイプ別 (Tier 1, Tier 2, and Tier 3)
    • 世界の患者腫瘍組織移植モデルのメーカーの地理的分布
  • M&A, 拡張計画

第4章 市場規模:タイプ別

  • 世界の患者腫瘍組織移植モデルの販売:タイプ別
    • 世界の患者腫瘍組織移植モデルの販売実績:タイプ別 (2017-2022)
    • 世界の患者腫瘍組織移植モデルの販売予測:タイプ別 (2023-2028)
    • 世界の患者腫瘍組織移植モデルの販売市場シェア:タイプ別 (2017-2028)
  • 世界の患者腫瘍組織移植モデルの収益:タイプ別
    • 世界の患者腫瘍組織移植モデルの収益実績:タイプ別 (2017-2022)
    • 世界の患者腫瘍組織移植モデルの収益予測:タイプ別 (2023-2028)
    • 世界の患者腫瘍組織移植モデルの収益市場シェア:タイプ別 (2017-2028)
  • 世界の患者腫瘍組織移植モデルの価格:タイプ別
    • 世界の患者腫瘍組織移植モデルの価格:タイプ別 (2017-2022)
    • 世界の患者腫瘍組織移植モデルの価格予測:タイプ別 (2023-2028)

第5章 市場規模:アプリケーション別

  • 世界の患者腫瘍組織移植モデルの販売:アプリケーション別
    • 世界の患者腫瘍組織移植モデルの販売実績:アプリケーション別 (2017-2022)
    • 世界の患者腫瘍組織移植モデルの販売予測:アプリケーション別 (2023-2028)
    • 世界の患者腫瘍組織移植モデルの販売市場シェア:アプリケーション別 (2017-2028)
  • 世界の患者腫瘍組織移植モデルの収益:アプリケーション別
    • 世界の患者腫瘍組織移植モデルの収益実績:アプリケーション別 (2017-2022)
    • 世界の患者腫瘍組織移植モデルの収益予測:アプリケーション別 (2023-2028)
    • 世界の患者腫瘍組織移植モデルの収益市場シェア:アプリケーション別 (2017-2028)
  • 世界の患者腫瘍組織移植モデルの価格:アプリケーション別
    • 世界の患者腫瘍組織移植モデルの価格:アプリケーション別 (2017-2022)
    • 世界の患者腫瘍組織移植モデルの価格予測:アプリケーション別 (2023-2028)

第6章 北米

  • 北米の患者腫瘍組織移植モデル 市場規模:タイプ別
    • 北米の患者腫瘍組織移植モデルの販売:タイプ別 (2017-2028)
    • 北米の患者腫瘍組織移植モデルの収益:タイプ別 (2017-2028)
  • 北米の患者腫瘍組織移植モデル 市場規模:アプリケーション別
    • 北米の患者腫瘍組織移植モデルの販売:アプリケーション別 (2017-2028)
    • 北米の患者腫瘍組織移植モデルの収益:アプリケーション別 (2017-2028)
  • 北米の患者腫瘍組織移植モデル 市場規模:国別
    • 北米の患者腫瘍組織移植モデルの販売:国別 (2017-2028)
    • 北米の患者腫瘍組織移植モデルの収益:国別 (2017-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の患者腫瘍組織移植モデル 市場規模:タイプ別
    • 欧州の患者腫瘍組織移植モデルの販売:タイプ別 (2017-2028)
    • 欧州の患者腫瘍組織移植モデルの収益:タイプ別 (2017-2028)
  • 欧州の患者腫瘍組織移植モデル 市場規模:アプリケーション別
    • 欧州の患者腫瘍組織移植モデルの販売:アプリケーション別 (2017-2028)
    • 欧州の患者腫瘍組織移植モデルの収益:アプリケーション別 (2017-2028)
  • 欧州の患者腫瘍組織移植モデル 市場規模:国別
    • 欧州の患者腫瘍組織移植モデルの販売:国別 (2017-2028)
    • 欧州の患者腫瘍組織移植モデルの収益:国別 (2017-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 アジア太平洋

  • アジア太平洋の患者腫瘍組織移植モデル 市場規模:タイプ別
    • アジア太平洋の患者腫瘍組織移植モデルの販売:タイプ別 (2017-2028)
    • アジア太平洋の患者腫瘍組織移植モデルの収益:タイプ別 (2017-2028)
  • アジア太平洋の患者腫瘍組織移植モデル 市場規模:アプリケーション別
    • アジア太平洋の患者腫瘍組織移植モデルの販売:アプリケーション別 (2017-2028)
    • アジア太平洋の患者腫瘍組織移植モデルの収益:アプリケーション別 (2017-2028)
  • アジア太平洋の患者腫瘍組織移植モデル 市場規模:地域別
    • アジア太平洋の患者腫瘍組織移植モデルの販売:地域別 (2017-2028)
    • アジア太平洋の患者腫瘍組織移植モデルの収益:地域別 (2017-2028)
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • 台湾
    • インドネシア
    • タイ
    • マレーシア
    • フィリピン

第9章 ラテンアメリカ

  • ラテンアメリカの患者腫瘍組織移植モデル 市場規模:タイプ別
    • ラテンアメリカの患者腫瘍組織移植モデルの販売:タイプ別 (2017-2028)
    • ラテンアメリカの患者腫瘍組織移植モデルの収益:タイプ別 (2017-2028)
  • ラテンアメリカの患者腫瘍組織移植モデル 市場規模:アプリケーション別
    • ラテンアメリカの患者腫瘍組織移植モデルの販売:アプリケーション別 (2017-2028)
    • ラテンアメリカの患者腫瘍組織移植モデルの収益:アプリケーション別 (2017-2028)
  • ラテンアメリカの患者腫瘍組織移植モデル 市場規模:国別
    • ラテンアメリカの患者腫瘍組織移植モデルの販売:国別 (2017-2028)
    • ラテンアメリカの患者腫瘍組織移植モデルの収益:国別 (2017-2028)
    • メキシコ
    • ブラジル
    • アルゼンチン

第10章 中東・アフリカ

  • 中東・アフリカの患者腫瘍組織移植モデル 市場規模:タイプ別
    • 中東・アフリカの患者腫瘍組織移植モデルの販売:タイプ別 (2017-2028)
    • 中東・アフリカの患者腫瘍組織移植モデルの収益:タイプ別 (2017-2028)
  • 中東・アフリカの患者腫瘍組織移植モデル 市場規模:アプリケーション別
    • 中東・アフリカの患者腫瘍組織移植モデルの販売:アプリケーション別 (2017-2028)
    • 中東・アフリカの患者腫瘍組織移植モデルの収益:アプリケーション別 (2017-2028)
  • 中東・アフリカの患者腫瘍組織移植モデル 市場規模:国別
    • 中東・アフリカの患者腫瘍組織移植モデルの販売:国別 (2017-2028)
    • 中東・アフリカの患者腫瘍組織移植モデルの収益:国別 (2017-2028)
    • トルコ
    • サウジアラビア

第11章 企業プロファイル

  • Crown Bioscience Inc. (US)
  • WuXi AppTec (China)
  • Champions Oncology (US)
  • The Jackson Laboratory (US)
  • ONCODESIGN (France)
  • Charles River Laboratories International (US)
  • EPO Berlin-Buch GmBH (Germany)
  • Shanghai LIDE Biotech Co., Ltd (China)
  • Xentech (France)
  • Horizon Discovery Group PLC (UK)
  • Urolead (France)
  • Explora BioLabs (US)

第12章 業界チェーンと販売チャネルの分析

  • 患者腫瘍組織移植モデル 業界チェーン分析
  • 患者腫瘍組織移植モデル 主要原材料分析
    • 主要原材料分析
    • 原材料の主要サプライヤー
  • 患者腫瘍組織移植モデル 生産形態とプロセス
  • 患者腫瘍組織移植モデル 販売およびマーケティング
    • 患者腫瘍組織移植モデル 販売チャネル
    • 患者腫瘍組織移植モデル 卸業者
  • 患者腫瘍組織移植モデル 顧客

第13章 市場の促進要因, 機会, 課題とリスク要因の分析

  • 患者腫瘍組織移植モデル 業界動向
  • 患者腫瘍組織移植モデル 市場の促進要因
  • 患者腫瘍組織移植モデル 市場の課題
  • 患者腫瘍組織移植モデル 市場の抑制要因

第14章 世界の患者腫瘍組織移植モデルの主な市場調査結果

第15章 付録

図表

LIST OF TABLES

List of Tables

  • Table 1. Global Patient Derived Xenograft Models Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 2. Major Manufacturers of Mice Models
  • Table 3. Major Manufacturers of Rat Models
  • Table 4. Global Patient Derived Xenograft Models Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 5. Global Patient Derived Xenograft Models Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 6. Global Patient Derived Xenograft Models Sales by Region (2017-2022) & (K Units)
  • Table 7. Global Patient Derived Xenograft Models Sales Market Share by Region (2017-2022)
  • Table 8. Global Patient Derived Xenograft Models Sales by Region (2023-2028) & (K Units)
  • Table 9. Global Patient Derived Xenograft Models Sales Market Share by Region (2023-2028)
  • Table 10. Global Patient Derived Xenograft Models Revenue by Region (2017-2022) & (US$ Million)
  • Table 11. Global Patient Derived Xenograft Models Revenue Market Share by Region (2017-2022)
  • Table 12. Global Patient Derived Xenograft Models Revenue by Region (2023-2028) & (US$ Million)
  • Table 13. Global Patient Derived Xenograft Models Revenue Market Share by Region (2023-2028)
  • Table 14. Global Patient Derived Xenograft Models Sales by Manufacturers (2017-2022) & (K Units)
  • Table 15. Global Patient Derived Xenograft Models Sales Share by Manufacturers (2017-2022)
  • Table 16. Global Patient Derived Xenograft Models Revenue by Manufacturers (2017-2022) & (US$ Million)
  • Table 17. Global Patient Derived Xenograft Models Revenue Share by Manufacturers (2017-2022)
  • Table 18. Patient Derived Xenograft Models Price by Manufacturers (2017-2022) &(USD/Unit)
  • Table 19. Global Patient Derived Xenograft Models Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 20. Global Patient Derived Xenograft Models by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patient Derived Xenograft Models as of 2021)
  • Table 21. Patient Derived Xenograft Models Manufacturing Base Distribution and Headquarters
  • Table 22. Manufacturers Patient Derived Xenograft Models Product Offered
  • Table 23. Date of Manufacturers Enter into Patient Derived Xenograft Models Market
  • Table 24. Mergers & Acquisitions, Expansion Plans
  • Table 25. Global Patient Derived Xenograft Models Sales by Type (2017-2022) & (K Units)
  • Table 26. Global Patient Derived Xenograft Models Sales by Type (2023-2028) & (K Units)
  • Table 27. Global Patient Derived Xenograft Models Sales Share by Type (2017-2022)
  • Table 28. Global Patient Derived Xenograft Models Sales Share by Type (2023-2028)
  • Table 29. Global Patient Derived Xenograft Models Revenue by Type (2017-2022) & (US$ Million)
  • Table 30. Global Patient Derived Xenograft Models Revenue by Type (2023-2028) & (US$ Million)
  • Table 31. Global Patient Derived Xenograft Models Revenue Share by Type (2017-2022)
  • Table 32. Global Patient Derived Xenograft Models Revenue Share by Type (2023-2028)
  • Table 33. Patient Derived Xenograft Models Price by Type (2017-2022) & (USD/Unit)
  • Table 34. Global Patient Derived Xenograft Models Price Forecast by Type (2023-2028) & (USD/Unit)
  • Table 35. Global Patient Derived Xenograft Models Sales by Application (2017-2022) & (K Units)
  • Table 36. Global Patient Derived Xenograft Models Sales by Application (2023-2028) & (K Units)
  • Table 37. Global Patient Derived Xenograft Models Sales Share by Application (2017-2022)
  • Table 38. Global Patient Derived Xenograft Models Sales Share by Application (2023-2028)
  • Table 39. Global Patient Derived Xenograft Models Revenue by Application (2017-2022) & (US$ Million)
  • Table 40. Global Patient Derived Xenograft Models Revenue by Application (2023-2028) & (US$ Million)
  • Table 41. Global Patient Derived Xenograft Models Revenue Share by Application (2017-2022)
  • Table 42. Global Patient Derived Xenograft Models Revenue Share by Application (2023-2028)
  • Table 43. Patient Derived Xenograft Models Price by Application (2017-2022) & (USD/Unit)
  • Table 44. Global Patient Derived Xenograft Models Price Forecast by Application (2023-2028) & (USD/Unit)
  • Table 45. North America Patient Derived Xenograft Models Sales by Type (2017-2022) & (K Units)
  • Table 46. North America Patient Derived Xenograft Models Sales by Type (2023-2028) & (K Units)
  • Table 47. North America Patient Derived Xenograft Models Revenue by Type (2017-2022) & (US$ Million)
  • Table 48. North America Patient Derived Xenograft Models Revenue by Type (2023-2028) & (US$ Million)
  • Table 49. North America Patient Derived Xenograft Models Sales by Application (2017-2022) & (K Units)
  • Table 50. North America Patient Derived Xenograft Models Sales by Application (2023-2028) & (K Units)
  • Table 51. North America Patient Derived Xenograft Models Revenue by Application (2017-2022) & (US$ Million)
  • Table 52. North America Patient Derived Xenograft Models Revenue by Application (2023-2028) & (US$ Million)
  • Table 53. North America Patient Derived Xenograft Models Sales by Country (2017-2022) & (K Units)
  • Table 54. North America Patient Derived Xenograft Models Sales by Country (2023-2028) & (K Units)
  • Table 55. North America Patient Derived Xenograft Models Revenue by Country (2017-2022) & (US$ Million)
  • Table 56. North America Patient Derived Xenograft Models Revenue by Country (2023-2028) & (US$ Million)
  • Table 57. Europe Patient Derived Xenograft Models Sales by Type (2017-2022) & (K Units)
  • Table 58. Europe Patient Derived Xenograft Models Sales by Type (2023-2028) & (K Units)
  • Table 59. Europe Patient Derived Xenograft Models Revenue by Type (2017-2022) & (US$ Million)
  • Table 60. Europe Patient Derived Xenograft Models Revenue by Type (2023-2028) & (US$ Million)
  • Table 61. Europe Patient Derived Xenograft Models Sales by Application (2017-2022) & (K Units)
  • Table 62. Europe Patient Derived Xenograft Models Sales by Application (2023-2028) & (K Units)
  • Table 63. Europe Patient Derived Xenograft Models Revenue by Application (2017-2022) & (US$ Million)
  • Table 64. Europe Patient Derived Xenograft Models Revenue by Application (2023-2028) & (US$ Million)
  • Table 65. Europe Patient Derived Xenograft Models Sales by Country (2017-2022) & (K Units)
  • Table 66. Europe Patient Derived Xenograft Models Sales by Country (2023-2028) & (K Units)
  • Table 67. Europe Patient Derived Xenograft Models Revenue by Country (2017-2022) & (US$ Million)
  • Table 68. Europe Patient Derived Xenograft Models Revenue by Country (2023-2028) & (US$ Million)
  • Table 69. Asia Pacific Patient Derived Xenograft Models Sales by Type (2017-2022) & (K Units)
  • Table 70. Asia Pacific Patient Derived Xenograft Models Sales by Type (2023-2028) & (K Units)
  • Table 71. Asia Pacific Patient Derived Xenograft Models Revenue by Type (2017-2022) & (US$ Million)
  • Table 72. Asia Pacific Patient Derived Xenograft Models Revenue by Type (2023-2028) & (US$ Million)
  • Table 73. Asia Pacific Patient Derived Xenograft Models Sales by Application (2017-2022) & (K Units)
  • Table 74. Asia Pacific Patient Derived Xenograft Models Sales by Application (2023-2028) & (K Units)
  • Table 75. Asia Pacific Patient Derived Xenograft Models Revenue by Application (2017-2022) & (US$ Million)
  • Table 76. Asia Pacific Patient Derived Xenograft Models Revenue by Application (2023-2028) & (US$ Million)
  • Table 77. Asia Pacific Patient Derived Xenograft Models Sales by Region (2017-2022) & (K Units)
  • Table 78. Asia Pacific Patient Derived Xenograft Models Sales by Region (2023-2028) & (K Units)
  • Table 79. Asia Pacific Patient Derived Xenograft Models Revenue by Region (2017-2022) & (US$ Million)
  • Table 80. Asia Pacific Patient Derived Xenograft Models Revenue by Region (2023-2028) & (US$ Million)
  • Table 81. Latin America Patient Derived Xenograft Models Sales by Type (2017-2022) & (K Units)
  • Table 82. Latin America Patient Derived Xenograft Models Sales by Type (2023-2028) & (K Units)
  • Table 83. Latin America Patient Derived Xenograft Models Revenue by Type (2017-2022) & (US$ Million)
  • Table 84. Latin America Patient Derived Xenograft Models Revenue by Type (2023-2028) & (US$ Million)
  • Table 85. Latin America Patient Derived Xenograft Models Sales by Application (2017-2022) & (K Units)
  • Table 86. Latin America Patient Derived Xenograft Models Sales by Application (2023-2028) & (K Units)
  • Table 87. Latin America Patient Derived Xenograft Models Revenue by Application (2017-2022) & (US$ Million)
  • Table 88. Latin America Patient Derived Xenograft Models Revenue by Application (2023-2028) & (US$ Million)
  • Table 89. Latin America Patient Derived Xenograft Models Sales by Country (2017-2022) & (K Units)
  • Table 90. Latin America Patient Derived Xenograft Models Sales by Country (2023-2028) & (K Units)
  • Table 91. Latin America Patient Derived Xenograft Models Revenue by Country (2017-2022) & (US$ Million)
  • Table 92. Latin America Patient Derived Xenograft Models Revenue by Country (2023-2028) & (US$ Million)
  • Table 93. Middle East and Africa Patient Derived Xenograft Models Sales by Type (2017-2022) & (K Units)
  • Table 94. Middle East and Africa Patient Derived Xenograft Models Sales by Type (2023-2028) & (K Units)
  • Table 95. Middle East and Africa Patient Derived Xenograft Models Revenue by Type (2017-2022) & (US$ Million)
  • Table 96. Middle East and Africa Patient Derived Xenograft Models Revenue by Type (2023-2028) & (US$ Million)
  • Table 97. Middle East and Africa Patient Derived Xenograft Models Sales by Application (2017-2022) & (K Units)
  • Table 98. Middle East and Africa Patient Derived Xenograft Models Sales by Application (2023-2028) & (K Units)
  • Table 99. Middle East and Africa Patient Derived Xenograft Models Revenue by Application (2017-2022) & (US$ Million)
  • Table 100. Middle East and Africa Patient Derived Xenograft Models Revenue by Application (2023-2028) & (US$ Million)
  • Table 101. Middle East and Africa Patient Derived Xenograft Models Sales by Country (2017-2022) & (K Units)
  • Table 102. Middle East and Africa Patient Derived Xenograft Models Sales by Country (2023-2028) & (K Units)
  • Table 103. Middle East and Africa Patient Derived Xenograft Models Revenue by Country (2017-2022) & (US$ Million)
  • Table 104. Middle East and Africa Patient Derived Xenograft Models Revenue by Country (2023-2028) & (US$ Million)
  • Table 105. Crown Bioscience Inc. (US) Corporation Information
  • Table 106. Crown Bioscience Inc. (US) Description and Major Businesses
  • Table 107. Crown Bioscience Inc. (US) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 108. Crown Bioscience Inc. (US) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 109. Crown Bioscience Inc. (US) Recent Developments
  • Table 110. WuXi AppTec (China) Corporation Information
  • Table 111. WuXi AppTec (China) Description and Major Businesses
  • Table 112. WuXi AppTec (China) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 113. WuXi AppTec (China) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 114. WuXi AppTec (China) Recent Developments
  • Table 115. Champions Oncology (US) Corporation Information
  • Table 116. Champions Oncology (US) Description and Major Businesses
  • Table 117. Champions Oncology (US) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 118. Champions Oncology (US) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 119. Champions Oncology (US) Recent Developments
  • Table 120. The Jackson Laboratory (US) Corporation Information
  • Table 121. The Jackson Laboratory (US) Description and Major Businesses
  • Table 122. The Jackson Laboratory (US) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 123. The Jackson Laboratory (US) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 124. The Jackson Laboratory (US) Recent Developments
  • Table 125. ONCODESIGN (France) Corporation Information
  • Table 126. ONCODESIGN (France) Description and Major Businesses
  • Table 127. ONCODESIGN (France) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 128. ONCODESIGN (France) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 129. ONCODESIGN (France) Recent Developments
  • Table 130. Charles River Laboratories International (US) Corporation Information
  • Table 131. Charles River Laboratories International (US) Description and Major Businesses
  • Table 132. Charles River Laboratories International (US) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 133. Charles River Laboratories International (US) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 134. Charles River Laboratories International (US) Recent Developments
  • Table 135. EPO Berlin-Buch GmBH (Germany) Corporation Information
  • Table 136. EPO Berlin-Buch GmBH (Germany) Description and Major Businesses
  • Table 137. EPO Berlin-Buch GmBH (Germany) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 138. EPO Berlin-Buch GmBH (Germany) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 139. EPO Berlin-Buch GmBH (Germany) Recent Developments
  • Table 140. Shanghai LIDE Biotech Co., Ltd (China) Corporation Information
  • Table 141. Shanghai LIDE Biotech Co., Ltd (China) Description and Major Businesses
  • Table 142. Shanghai LIDE Biotech Co., Ltd (China) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 143. Shanghai LIDE Biotech Co., Ltd (China) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 144. Shanghai LIDE Biotech Co., Ltd (China) Recent Developments
  • Table 145. Xentech (France) Corporation Information
  • Table 146. Xentech (France) Description and Major Businesses
  • Table 147. Xentech (France) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 148. Xentech (France) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 149. Xentech (France) Recent Developments
  • Table 150. Horizon Discovery Group PLC (UK) Corporation Information
  • Table 151. Horizon Discovery Group PLC (UK) Description and Major Businesses
  • Table 152. Horizon Discovery Group PLC (UK) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 153. Horizon Discovery Group PLC (UK) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 154. Horizon Discovery Group PLC (UK) Recent Developments
  • Table 155. Urolead (France) Corporation Information
  • Table 156. Urolead (France) Description and Major Businesses
  • Table 157. Urolead (France) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 158. Urolead (France) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 159. Urolead (France) Recent Developments
  • Table 160. Explora BioLabs (US) Corporation Information
  • Table 161. Explora BioLabs (US) Description and Major Businesses
  • Table 162. Explora BioLabs (US) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 163. Explora BioLabs (US) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 164. Explora BioLabs (US) Recent Developments
  • Table 165. Key Raw Materials Lists
  • Table 166. Raw Materials Key Suppliers Lists
  • Table 167. Patient Derived Xenograft Models Distributors List
  • Table 168. Patient Derived Xenograft Models Customers List
  • Table 169. Patient Derived Xenograft Models Market Trends
  • Table 170. Patient Derived Xenograft Models Market Drivers
  • Table 171. Patient Derived Xenograft Models Market Challenges
  • Table 172. Patient Derived Xenograft Models Market Restraints
  • Table 173. Research Programs/Design for This Report
  • Table 174. Key Data Information from Secondary Sources
  • Table 175. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Patient Derived Xenograft Models Product Picture
  • Figure 3. Global Patient Derived Xenograft Models Market Share by Type in 2021 & 2028
  • Figure 3. Mice Models Product Picture
  • Figure 4. Rat Models Product Picture
  • Figure 5. Global Patient Derived Xenograft Models Market Share by Application in 2021 & 2028
  • Figure 6. Pharmaceutical & Biotechnology Companies
  • Figure 7. Contract Research Organizations
  • Figure 8. Academic & Research Institutions
  • Figure 9. Patient Derived Xenograft Models Report Years Considered
  • Figure 10. Global Patient Derived Xenograft Models Sales 2017-2028 (K Units)
  • Figure 11. Global Patient Derived Xenograft Models Revenue, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 12. Global Patient Derived Xenograft Models Revenue 2017-2028 (US$ Million)
  • Figure 13. Global Patient Derived Xenograft Models Revenue Market Share by Region in Percentage: 2021 Versus 2028
  • Figure 14. Global Patient Derived Xenograft Models Sales Market Share by Region (2017-2022)
  • Figure 15. Global Patient Derived Xenograft Models Sales Market Share by Region (2023-2028)
  • Figure 16. North America Patient Derived Xenograft Models Sales YoY (2017-2028) & (K Units)
  • Figure 17. North America Patient Derived Xenograft Models Revenue YoY (2017-2028) & (US$ Million)
  • Figure 18. Europe Patient Derived Xenograft Models Sales YoY (2017-2028) & (K Units)
  • Figure 19. Europe Patient Derived Xenograft Models Revenue YoY (2017-2028) & (US$ Million)
  • Figure 20. Asia-Pacific Patient Derived Xenograft Models Sales YoY (2017-2028) & (K Units)
  • Figure 21. Asia-Pacific Patient Derived Xenograft Models Revenue YoY (2017-2028) & (US$ Million)
  • Figure 22. Latin America Patient Derived Xenograft Models Sales YoY (2017-2028) & (K Units)
  • Figure 23. Latin America Patient Derived Xenograft Models Revenue YoY (2017-2028) & (US$ Million)
  • Figure 24. Middle East & Africa Patient Derived Xenograft Models Sales YoY (2017-2028) & (K Units)
  • Figure 25. Middle East & Africa Patient Derived Xenograft Models Revenue YoY (2017-2028) & (US$ Million)
  • Figure 26. The Patient Derived Xenograft Models Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
  • Figure 27. The Top 5 and 10 Largest Manufacturers of Patient Derived Xenograft Models in the World: Market Share by Patient Derived Xenograft Models Revenue in 2021
  • Figure 28. Global Patient Derived Xenograft Models Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
  • Figure 29. Global Patient Derived Xenograft Models Sales Market Share by Type (2017-2028)
  • Figure 30. Global Patient Derived Xenograft Models Revenue Market Share by Type (2017-2028)
  • Figure 31. Global Patient Derived Xenograft Models Sales Market Share by Application (2017-2028)
  • Figure 32. Global Patient Derived Xenograft Models Revenue Market Share by Application (2017-2028)
  • Figure 33. North America Patient Derived Xenograft Models Sales Market Share by Type (2017-2028)
  • Figure 34. North America Patient Derived Xenograft Models Revenue Market Share by Type (2017-2028)
  • Figure 35. North America Patient Derived Xenograft Models Sales Market Share by Application (2017-2028)
  • Figure 36. North America Patient Derived Xenograft Models Revenue Market Share by Application (2017-2028)
  • Figure 37. North America Patient Derived Xenograft Models Sales Share by Country (2017-2028)
  • Figure 38. North America Patient Derived Xenograft Models Revenue Share by Country (2017-2028)
  • Figure 39. U.S. Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
  • Figure 40. Canada Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
  • Figure 41. Europe Patient Derived Xenograft Models Sales Market Share by Type (2017-2028)
  • Figure 42. Europe Patient Derived Xenograft Models Revenue Market Share by Type (2017-2028)
  • Figure 43. Europe Patient Derived Xenograft Models Sales Market Share by Application (2017-2028)
  • Figure 44. Europe Patient Derived Xenograft Models Revenue Market Share by Application (2017-2028)
  • Figure 45. Europe Patient Derived Xenograft Models Sales Share by Country (2017-2028)
  • Figure 46. Europe Patient Derived Xenograft Models Revenue Share by Country (2017-2028)
  • Figure 47. Germany Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
  • Figure 48. France Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
  • Figure 49. U.K. Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
  • Figure 50. Italy Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
  • Figure 51. Russia Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
  • Figure 52. Asia Pacific Patient Derived Xenograft Models Sales Market Share by Type (2017-2028)
  • Figure 53. Asia Pacific Patient Derived Xenograft Models Revenue Market Share by Type (2017-2028)
  • Figure 54. Asia Pacific Patient Derived Xenograft Models Sales Market Share by Application (2017-2028)
  • Figure 55. Asia Pacific Patient Derived Xenograft Models Revenue Market Share by Application (2017-2028)
  • Figure 56. Asia Pacific Patient Derived Xenograft Models Sales Share by Region (2017-2028)
  • Figure 57. Asia Pacific Patient Derived Xenograft Models Revenue Share by Region (2017-2028)
  • Figure 58. China Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
  • Figure 59. Japan Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
  • Figure 60. South Korea Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
  • Figure 61. India Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
  • Figure 62. Australia Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
  • Figure 63. Taiwan Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
  • Figure 64. Indonesia Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
  • Figure 65. Thailand Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
  • Figure 66. Malaysia Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
  • Figure 67. Philippines Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
  • Figure 68. Latin America Patient Derived Xenograft Models Sales Market Share by Type (2017-2028)
  • Figure 69. Latin America Patient Derived Xenograft Models Revenue Market Share by Type (2017-2028)
  • Figure 70. Latin America Patient Derived Xenograft Models Sales Market Share by Application (2017-2028)
  • Figure 71. Latin America Patient Derived Xenograft Models Revenue Market Share by Application (2017-2028)
  • Figure 72. Latin America Patient Derived Xenograft Models Sales Share by Country (2017-2028)
  • Figure 73. Latin America Patient Derived Xenograft Models Revenue Share by Country (2017-2028)
  • Figure 74. Mexico Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
  • Figure 75. Brazil Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
  • Figure 76. Argentina Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
  • Figure 77. Middle East and Africa Patient Derived Xenograft Models Sales Market Share by Type (2017-2028)
  • Figure 78. Middle East and Africa Patient Derived Xenograft Models Revenue Market Share by Type (2017-2028)
  • Figure 79. Middle East and Africa Patient Derived Xenograft Models Sales Market Share by Application (2017-2028)
  • Figure 80. Middle East and Africa Patient Derived Xenograft Models Revenue Market Share by Application (2017-2028)
  • Figure 81. Middle East and Africa Patient Derived Xenograft Models Sales Share by Country (2017-2028)
  • Figure 82. Middle East and Africa Patient Derived Xenograft Models Revenue Share by Country (2017-2028)
  • Figure 83. Turkey Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
  • Figure 84. Saudi Arabia Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
  • Figure 85. U.A.E Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
  • Figure 86. Patient Derived Xenograft Models Value Chain
  • Figure 87. Patient Derived Xenograft Models Production Process
  • Figure 88. Channels of Distribution
  • Figure 89. Distributors Profiles
  • Figure 90. Bottom-up and Top-down Approaches for This Report
  • Figure 91. Data Triangulation
  • Figure 92. Key Executives Interviewed
目次

Market Analysis and Insights: Global Patient Derived Xenograft Models Market

Due to the COVID-19 pandemic, the global Patient Derived Xenograft Models market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Mice Models accounting for % of the Patient Derived Xenograft Models global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Pharmaceutical & Biotechnology Companies segment is altered to an % CAGR throughout this forecast period.

China Patient Derived Xenograft Models market size is valued at US$ million in 2021, while the US and Europe Patient Derived Xenograft Models are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Patient Derived Xenograft Models landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Patient Derived Xenograft Models include Crown Bioscience Inc. (US), WuXi AppTec (China), Champions Oncology (US), The Jackson Laboratory (US), ONCODESIGN (France), Charles River Laboratories International (US), EPO Berlin-Buch GmBH (Germany), Shanghai LIDE Biotech Co., Ltd (China) and Xentech (France), etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Global Patient Derived Xenograft Models Scope and Segment

Patient Derived Xenograft Models market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Patient Derived Xenograft Models market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Mice Models
  • Rat Models

Segment by Application

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Academic & Research Institutions

By Company

  • Crown Bioscience Inc. (US)
  • WuXi AppTec (China)
  • Champions Oncology (US)
  • The Jackson Laboratory (US)
  • ONCODESIGN (France)
  • Charles River Laboratories International (US)
  • EPO Berlin-Buch GmBH (Germany)
  • Shanghai LIDE Biotech Co., Ltd (China)
  • Xentech (France)
  • Horizon Discovery Group PLC (UK)
  • Urolead (France)
  • Explora BioLabs (US)

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Taiwan
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • U.A.E

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Patient Derived Xenograft Models Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Patient Derived Xenograft Models Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Mice Models
    • 1.2.3 Rat Models
  • 1.3 Market by Application
    • 1.3.1 Global Patient Derived Xenograft Models Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Pharmaceutical & Biotechnology Companies
    • 1.3.3 Contract Research Organizations
    • 1.3.4 Academic & Research Institutions
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Patient Derived Xenograft Models Sales Estimates and Forecasts 2017-2028
  • 2.2 Global Patient Derived Xenograft Models Revenue Estimates and Forecasts 2017-2028
  • 2.3 Global Patient Derived Xenograft Models Revenue by Region: 2017 VS 2021 VS 2028
  • 2.4 Global Patient Derived Xenograft Models Sales by Region
    • 2.4.1 Global Patient Derived Xenograft Models Sales by Region (2017-2022)
    • 2.4.2 Global Sales Patient Derived Xenograft Models by Region (2023-2028)
  • 2.5 Global Patient Derived Xenograft Models Revenue by Region
    • 2.5.1 Global Patient Derived Xenograft Models Revenue by Region (2017-2022)
    • 2.5.2 Global Patient Derived Xenograft Models Revenue by Region (2023-2028)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Patient Derived Xenograft Models Sales by Manufacturers
    • 3.1.1 Global Top Patient Derived Xenograft Models Manufacturers by Sales (2017-2022)
    • 3.1.2 Global Patient Derived Xenograft Models Sales Market Share by Manufacturers (2017-2022)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Patient Derived Xenograft Models in 2021
  • 3.2 Global Patient Derived Xenograft Models Revenue by Manufacturers
    • 3.2.1 Global Patient Derived Xenograft Models Revenue by Manufacturers (2017-2022)
    • 3.2.2 Global Patient Derived Xenograft Models Revenue Market Share by Manufacturers (2017-2022)
    • 3.2.3 Global Top 10 and Top 5 Companies by Patient Derived Xenograft Models Revenue in 2021
  • 3.3 Global Patient Derived Xenograft Models Sales Price by Manufacturers (2017-2022)
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Patient Derived Xenograft Models Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Patient Derived Xenograft Models Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Patient Derived Xenograft Models Sales by Type
    • 4.1.1 Global Patient Derived Xenograft Models Historical Sales by Type (2017-2022)
    • 4.1.2 Global Patient Derived Xenograft Models Forecasted Sales by Type (2023-2028)
    • 4.1.3 Global Patient Derived Xenograft Models Sales Market Share by Type (2017-2028)
  • 4.2 Global Patient Derived Xenograft Models Revenue by Type
    • 4.2.1 Global Patient Derived Xenograft Models Historical Revenue by Type (2017-2022)
    • 4.2.2 Global Patient Derived Xenograft Models Forecasted Revenue by Type (2023-2028)
    • 4.2.3 Global Patient Derived Xenograft Models Revenue Market Share by Type (2017-2028)
  • 4.3 Global Patient Derived Xenograft Models Price by Type
    • 4.3.1 Global Patient Derived Xenograft Models Price by Type (2017-2022)
    • 4.3.2 Global Patient Derived Xenograft Models Price Forecast by Type (2023-2028)

5 Market Size by Application

  • 5.1 Global Patient Derived Xenograft Models Sales by Application
    • 5.1.1 Global Patient Derived Xenograft Models Historical Sales by Application (2017-2022)
    • 5.1.2 Global Patient Derived Xenograft Models Forecasted Sales by Application (2023-2028)
    • 5.1.3 Global Patient Derived Xenograft Models Sales Market Share by Application (2017-2028)
  • 5.2 Global Patient Derived Xenograft Models Revenue by Application
    • 5.2.1 Global Patient Derived Xenograft Models Historical Revenue by Application (2017-2022)
    • 5.2.2 Global Patient Derived Xenograft Models Forecasted Revenue by Application (2023-2028)
    • 5.2.3 Global Patient Derived Xenograft Models Revenue Market Share by Application (2017-2028)
  • 5.3 Global Patient Derived Xenograft Models Price by Application
    • 5.3.1 Global Patient Derived Xenograft Models Price by Application (2017-2022)
    • 5.3.2 Global Patient Derived Xenograft Models Price Forecast by Application (2023-2028)

6 North America

  • 6.1 North America Patient Derived Xenograft Models Market Size by Type
    • 6.1.1 North America Patient Derived Xenograft Models Sales by Type (2017-2028)
    • 6.1.2 North America Patient Derived Xenograft Models Revenue by Type (2017-2028)
  • 6.2 North America Patient Derived Xenograft Models Market Size by Application
    • 6.2.1 North America Patient Derived Xenograft Models Sales by Application (2017-2028)
    • 6.2.2 North America Patient Derived Xenograft Models Revenue by Application (2017-2028)
  • 6.3 North America Patient Derived Xenograft Models Market Size by Country
    • 6.3.1 North America Patient Derived Xenograft Models Sales by Country (2017-2028)
    • 6.3.2 North America Patient Derived Xenograft Models Revenue by Country (2017-2028)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Patient Derived Xenograft Models Market Size by Type
    • 7.1.1 Europe Patient Derived Xenograft Models Sales by Type (2017-2028)
    • 7.1.2 Europe Patient Derived Xenograft Models Revenue by Type (2017-2028)
  • 7.2 Europe Patient Derived Xenograft Models Market Size by Application
    • 7.2.1 Europe Patient Derived Xenograft Models Sales by Application (2017-2028)
    • 7.2.2 Europe Patient Derived Xenograft Models Revenue by Application (2017-2028)
  • 7.3 Europe Patient Derived Xenograft Models Market Size by Country
    • 7.3.1 Europe Patient Derived Xenograft Models Sales by Country (2017-2028)
    • 7.3.2 Europe Patient Derived Xenograft Models Revenue by Country (2017-2028)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Patient Derived Xenograft Models Market Size by Type
    • 8.1.1 Asia Pacific Patient Derived Xenograft Models Sales by Type (2017-2028)
    • 8.1.2 Asia Pacific Patient Derived Xenograft Models Revenue by Type (2017-2028)
  • 8.2 Asia Pacific Patient Derived Xenograft Models Market Size by Application
    • 8.2.1 Asia Pacific Patient Derived Xenograft Models Sales by Application (2017-2028)
    • 8.2.2 Asia Pacific Patient Derived Xenograft Models Revenue by Application (2017-2028)
  • 8.3 Asia Pacific Patient Derived Xenograft Models Market Size by Region
    • 8.3.1 Asia Pacific Patient Derived Xenograft Models Sales by Region (2017-2028)
    • 8.3.2 Asia Pacific Patient Derived Xenograft Models Revenue by Region (2017-2028)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America Patient Derived Xenograft Models Market Size by Type
    • 9.1.1 Latin America Patient Derived Xenograft Models Sales by Type (2017-2028)
    • 9.1.2 Latin America Patient Derived Xenograft Models Revenue by Type (2017-2028)
  • 9.2 Latin America Patient Derived Xenograft Models Market Size by Application
    • 9.2.1 Latin America Patient Derived Xenograft Models Sales by Application (2017-2028)
    • 9.2.2 Latin America Patient Derived Xenograft Models Revenue by Application (2017-2028)
  • 9.3 Latin America Patient Derived Xenograft Models Market Size by Country
    • 9.3.1 Latin America Patient Derived Xenograft Models Sales by Country (2017-2028)
    • 9.3.2 Latin America Patient Derived Xenograft Models Revenue by Country (2017-2028)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

10 Middle East and Africa

  • 10.1 Middle East and Africa Patient Derived Xenograft Models Market Size by Type
    • 10.1.1 Middle East and Africa Patient Derived Xenograft Models Sales by Type (2017-2028)
    • 10.1.2 Middle East and Africa Patient Derived Xenograft Models Revenue by Type (2017-2028)
  • 10.2 Middle East and Africa Patient Derived Xenograft Models Market Size by Application
    • 10.2.1 Middle East and Africa Patient Derived Xenograft Models Sales by Application (2017-2028)
    • 10.2.2 Middle East and Africa Patient Derived Xenograft Models Revenue by Application (2017-2028)
  • 10.3 Middle East and Africa Patient Derived Xenograft Models Market Size by Country
    • 10.3.1 Middle East and Africa Patient Derived Xenograft Models Sales by Country (2017-2028)
    • 10.3.2 Middle East and Africa Patient Derived Xenograft Models Revenue by Country (2017-2028)
    • 10.3.3 Turkey
    • 10.3.4 Saudi Arabia

11 Company Profiles

  • 11.1 Crown Bioscience Inc. (US)
    • 11.1.1 Crown Bioscience Inc. (US) Corporation Information
    • 11.1.2 Crown Bioscience Inc. (US) Overview
    • 11.1.3 Crown Bioscience Inc. (US) Patient Derived Xenograft Models Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.1.4 Crown Bioscience Inc. (US) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Crown Bioscience Inc. (US) Recent Developments
  • 11.2 WuXi AppTec (China)
    • 11.2.1 WuXi AppTec (China) Corporation Information
    • 11.2.2 WuXi AppTec (China) Overview
    • 11.2.3 WuXi AppTec (China) Patient Derived Xenograft Models Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.2.4 WuXi AppTec (China) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 WuXi AppTec (China) Recent Developments
  • 11.3 Champions Oncology (US)
    • 11.3.1 Champions Oncology (US) Corporation Information
    • 11.3.2 Champions Oncology (US) Overview
    • 11.3.3 Champions Oncology (US) Patient Derived Xenograft Models Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.3.4 Champions Oncology (US) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Champions Oncology (US) Recent Developments
  • 11.4 The Jackson Laboratory (US)
    • 11.4.1 The Jackson Laboratory (US) Corporation Information
    • 11.4.2 The Jackson Laboratory (US) Overview
    • 11.4.3 The Jackson Laboratory (US) Patient Derived Xenograft Models Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.4.4 The Jackson Laboratory (US) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 The Jackson Laboratory (US) Recent Developments
  • 11.5 ONCODESIGN (France)
    • 11.5.1 ONCODESIGN (France) Corporation Information
    • 11.5.2 ONCODESIGN (France) Overview
    • 11.5.3 ONCODESIGN (France) Patient Derived Xenograft Models Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.5.4 ONCODESIGN (France) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 ONCODESIGN (France) Recent Developments
  • 11.6 Charles River Laboratories International (US)
    • 11.6.1 Charles River Laboratories International (US) Corporation Information
    • 11.6.2 Charles River Laboratories International (US) Overview
    • 11.6.3 Charles River Laboratories International (US) Patient Derived Xenograft Models Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.6.4 Charles River Laboratories International (US) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Charles River Laboratories International (US) Recent Developments
  • 11.7 EPO Berlin-Buch GmBH (Germany)
    • 11.7.1 EPO Berlin-Buch GmBH (Germany) Corporation Information
    • 11.7.2 EPO Berlin-Buch GmBH (Germany) Overview
    • 11.7.3 EPO Berlin-Buch GmBH (Germany) Patient Derived Xenograft Models Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.7.4 EPO Berlin-Buch GmBH (Germany) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 EPO Berlin-Buch GmBH (Germany) Recent Developments
  • 11.8 Shanghai LIDE Biotech Co., Ltd (China)
    • 11.8.1 Shanghai LIDE Biotech Co., Ltd (China) Corporation Information
    • 11.8.2 Shanghai LIDE Biotech Co., Ltd (China) Overview
    • 11.8.3 Shanghai LIDE Biotech Co., Ltd (China) Patient Derived Xenograft Models Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.8.4 Shanghai LIDE Biotech Co., Ltd (China) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 Shanghai LIDE Biotech Co., Ltd (China) Recent Developments
  • 11.9 Xentech (France)
    • 11.9.1 Xentech (France) Corporation Information
    • 11.9.2 Xentech (France) Overview
    • 11.9.3 Xentech (France) Patient Derived Xenograft Models Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.9.4 Xentech (France) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 Xentech (France) Recent Developments
  • 11.10 Horizon Discovery Group PLC (UK)
    • 11.10.1 Horizon Discovery Group PLC (UK) Corporation Information
    • 11.10.2 Horizon Discovery Group PLC (UK) Overview
    • 11.10.3 Horizon Discovery Group PLC (UK) Patient Derived Xenograft Models Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.10.4 Horizon Discovery Group PLC (UK) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.10.5 Horizon Discovery Group PLC (UK) Recent Developments
  • 11.11 Urolead (France)
    • 11.11.1 Urolead (France) Corporation Information
    • 11.11.2 Urolead (France) Overview
    • 11.11.3 Urolead (France) Patient Derived Xenograft Models Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.11.4 Urolead (France) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.11.5 Urolead (France) Recent Developments
  • 11.12 Explora BioLabs (US)
    • 11.12.1 Explora BioLabs (US) Corporation Information
    • 11.12.2 Explora BioLabs (US) Overview
    • 11.12.3 Explora BioLabs (US) Patient Derived Xenograft Models Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.12.4 Explora BioLabs (US) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.12.5 Explora BioLabs (US) Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Patient Derived Xenograft Models Industry Chain Analysis
  • 12.2 Patient Derived Xenograft Models Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Patient Derived Xenograft Models Production Mode & Process
  • 12.4 Patient Derived Xenograft Models Sales and Marketing
    • 12.4.1 Patient Derived Xenograft Models Sales Channels
    • 12.4.2 Patient Derived Xenograft Models Distributors
  • 12.5 Patient Derived Xenograft Models Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Patient Derived Xenograft Models Industry Trends
  • 13.2 Patient Derived Xenograft Models Market Drivers
  • 13.3 Patient Derived Xenograft Models Market Challenges
  • 13.4 Patient Derived Xenograft Models Market Restraints

14 Key Findings in The Global Patient Derived Xenograft Models Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer